Evaluation of physical constraints related to the use of medical devices during the cytotoxic compounding

C. Roch1, N. Martelli1, J. Vernois2, D. Pradeau3, E. Caudron1,4 1 Service Pharmacie, Hôpital européen Georges Pompidou, AP-HP, France
2 Unité Qualité et Essais Hospitaliers, AGEPS, AP-HP, France
3 Laboratoire de Physico-chimie, AGEPS, AP-HP, France
4 Laboratoire de chimie analytique Lyp(Sys)2, Université Paris Sud, France


In order to reduce musculoskeletal disorders (MSD) of operators, flow resistance across syringe and other different medical devices necessary for the compounding of cytotoxic, has been evaluated.

Materials and methods

The medical devices tested were Iflow® ambulatory infusion pump, Freeflex plus Luer-Lock® bags and three types of luer-lock® connectors (CAIR old and new references, CODAN) associated to a 5% glucose bags. Measurements of the flow resistance in tension and compression of a 5% glucose solution (V= 50 mL) were performed with a dynamometer for 100 to 1000 mm/min speed (or sampling/filling time of 4.8 to 48 seconds). Each measurement was repeated 5 times.


Convenient sampling force should be from 20 to 30 N, including the whole system, according to operators. However, compounding of the ambulatory infusion pump was very restrictive and required higher forces (95 N to 140 N). When considering connectors and bags, compressive forces were lower than traction forces as expected. Tension forces ranged from 19 ± 7 N to 59 ± 11 N on Luer-Lock® bags. The connectors ranged from 12 ± 3 N to 59 ± 7 N and 19 ± 11N to 63 ± 3 N for CODAN and CAIR old references respectively. The last new reference showed a significant lower force with 16 ± 9 N to 27 ± 3 N.

Discussion - Conclusion

Physical constraints strongly depend of the medical device and operators. Our study allowed a judicious choice between connectors. The new CAIR reference substantially improved the conditions of compounding of the cytotoxic drug. Due to the arduousness of ambulatory infusion pump filling, a filling aid pump was implemented to reduce risk of MSD operators.

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data